Search results

{{r|Coronary heart disease}}

...a deficiency of [[cystathionine beta-synthase]] and is a risk factor for [[coronary heart disease|coronary vascular disease]]."<ref>{{MeSH|Hyperhomocysteinemia}}</ref><ref n ...have a 20% increase in serum homocysteine levels and may have increased [[coronary heart disease]].<ref name="pmid17124224"/><ref name="pmid12446535"/><ref name="OMIM - MTH

[[Hypercholesterolemia]] may contribute to [[coronary heart disease]], [[stroke]], and other complications.

...7 years of treatment with [[statin]]s, the [[relative risk reduction]] of coronary heart disease events is decreased by approximately 30%<ref name="pmid11306236">{{cite jou

* At least 3 risk factors for coronary artery disease (family history or [[coronary heart disease]], [[hypertension]], [[hypercholesterolemia]], [[diabetes]], current smokin

...le=Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HE

...r=Osganian SK, Stampfer MJ, Rimm E, ''et al'' |title=Vitamin C and risk of coronary heart disease in women |journal=J. Am. Coll. Cardiol. |volume=42 |issue=2 |pages=246–52

...nhibitor]]. It is used in the [[secondary prevention]] of [[stroke]] and [[coronary heart disease]]. Inadequate effect in patients with [[coronary heart disease]] can be due to CYP2C19 loss-of-function alleles which are associated with

...y embolism]], [[computed tomographic cardiac angiography]] for detecting [[coronary heart disease]]<ref name="pmid18691486">{{cite journal |author=Stein PD, Yaekoub AY, Matt

...50 mmol/day] is projected to reduce the annual number of new cases of CHD [coronary heart disease] by 60,000 to 120,000, stroke by 32,000 to 66,000, and myocardial infarctio

...le=Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HE

...M et al.| title=Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease. | journal=N Engl J Med | year= 2010 | volume= | issue= | pages= | pmid=

...cgi/content/abstract/302/1/37 }}</ref>, its presence may help prediction [[coronary heart disease]]. ...found that the ability of the CRP to add to other methods of predicting [[coronary heart disease]] such as the [http://hp2010.nhlbihin.net/atpiii/calculator.asp Framingham

...Study (UKPDS) Group| title=The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). | journal=Clin Sci (Lond) | year= 2001 | vo

...14:45, 25 October 2011 (UTC)'Obesity is a well-established risk factor for coronary heart disease (CHD), but whether regional fat distribution contributes independently to r

...y embolism]], [[computed tomographic cardiac angiography]] for detecting [[coronary heart disease]]<ref name="pmid18691486">{{cite journal |author=Stein PD, Yaekoub AY, Matt

====Coronary heart disease and mortality==== The benefit of fish oil on [[coronary heart disease]] and mortality is controversial with conflicting conclusions reached by a

...not clear whether all of the included trials allowed patients with active coronary heart disease who would have most benefitted from a [[adrenergic beta-antagonist]].<ref n ...ther antihypertensive agents; however patients were included if they had [[coronary heart disease]] and benefit was confined to patients with prior [[myocardial infarction]]

...ood (called the [[coronary artery|coronary arteries]]). The usual cause of coronary heart disease is [[atherosclerosis]]. ...tion of coronary heart disease is multifactorial. About 3/4 of the risk of coronary heart disease is due to three risk factors: [[hypercholesterolemia]] (total cholesterol >

...mount of sleep may be associated with [[cardiovascular disease]] such as [[coronary heart disease]] and [[stroke]].<ref name="pmid19001199">{{cite journal |author=Eguchi K,